PWNHEALTH CHICAGO LLC – Trademark Portfolio

Entity Type: 16

PWNHEALTH CHICAGO LLC holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 4 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include HOME ACCESS and LAB TEST AT HOME. The owner is based in Austin, TX.

823 Congress Avenue, Suite 1200

Austin, TX 78701

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

PWNHEALTH CHICAGO LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (4 filings)

Surgical, medical, dental and veterinary apparatus and instruments

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does PWNHEALTH CHICAGO LLC have?

PWNHEALTH CHICAGO LLC has 5 U.S. trademarks filed with the USPTO. Of these, 3 registered, 2 cancelled.

What trademark classes does PWNHEALTH CHICAGO LLC file in?

PWNHEALTH CHICAGO LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are PWNHEALTH CHICAGO LLC's most well-known trademarks?

PWNHEALTH CHICAGO LLC's registered trademark portfolio includes well-known marks such as HOME ACCESS and LAB TEST AT HOME. These are among 3 currently registered trademarks in the portfolio.

What is PWNHEALTH CHICAGO LLC's trademark registration success rate?

PWNHEALTH CHICAGO LLC has a 60% trademark registration rate, with 3 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.